Searched for
PV APPAJI
Government in talks with various markets to accept Indian drug normsIndia is nudging various semi-regulated markets like Myanmar and Kenya to accept its drug standards, instead of the US or British norms.- Government lobbying with unregulated markets to accept Indian drug standardsIndia’s commerce ministry is in talks with at least 10 nregulated economies and will have a detailed meeting with their regulators.
- Chinese aid norms curb exports of Indian drugs to markets in Africa, Asia & eastern EuropeIndia exported $15.2 billion medicines in 2014-15 and around 15% of these medicines were sold in economies that are availing concessional l...
- India woos Italian bulk drug makers to cut dependency on Chinese APIsIncreased cost of production and other European economy related constraints had led to several local drug makers shutting down their unviab...
- India may suffer Rs 6,300 crore loss in pharma exportsIndia may suffer at least Rs 6,300 crore of loss in export of pharmaceutical products this fiscal following the on around 700 generic drugs...
- India to open drugs database to global regulatorsIndia had exported medicines worth $15.2 billion (about Rs 97,000 crore) in 2014-15, an increase of 5% over the previous year’s figure.
- Indian pharma exports may have grown 2.2 per cent to $15.2 billion in FY15: PharmexcilAppaji said the growth in the US would be around 13 per cent last year despite various regulatory issues compared with 18 per cent earlier.
- India wants its officials during USFDA inspections at drug unitsIn many cases, these companies have been barred from selling their drugs in the US and other countries, although Indian firms account for a...
- Indian pharmaceutical exports to cross Rs 1 lakh crore markExport of pharmaceutical products from India are set to cross Rs 1 lakh crore mark this fiscal from Rs 90,000 crore during fiscal .
- Argentina opens $6 billion industry for Indian pharmaceutical companiesWith effect from August 8, the Latin American nation has included India on the list of countries that can supply medicines to it.
- Pharmaceuticals Export Promotion Council recommends two more seaports for exportsAndhra Pradesh (united) with nearly Rs 30,000 crore exports used to be in the second position after Maharashtra in terms of overall pharma ...
- Pharmexcil plans warehouse in Nigeria to boost trade to AfricaPharmexcil is mulling to establish a warehouse in Nigeria to encourage export business of small- and medium-sized drug companies to African...
- India to showcase drugmaking facilities to global regulatorsIndia is showcasing its best pharmaceutical manufacturing facilities to regulators from emerging economies to counter adverse publicity.
- Biosimilars to replace 70% of chemical drugs in 2 decadesBiosimilars products are set to replace some 70% of global chemical drugs over the next couple of decades on account of safety parameters.
- Now, China turns the heat on India’s vaccine makersAfter spitting fire at Indian pharma sector's active pharma ingredients (APIs) makers, the Chinese dragon is now turning its wrath on India...
- Government should help local pharma compete with China: PharmexcilThe government should make efforts to strengthen the domestic industry in view of rising bulk drug imports from China.
- Andhra Pradesh power cuts to hit pharmaceutical exports targetSevere power cuts in Andhra Pradesh have forced the Pharmexcil to slash the country's pharmaceutical export growth projections for this fis...
- Pharmaceutical Export Promotion Council of India seeks clarity from US on new generic drug fee normsPharmexcil has sought clarity from the United States Food and Drug Administration (USFDA ) on the new generic drug user fee norms.
- Pharma exports may grow by 20% this fiscal and touch $12 billion mark: PharmexcilAccording to international consulting firm Pricewaterhouse, by 2020 the pharmaceutical market is anticipated to be at USD 1.3 trillion.
- Drug exports up 31% on weak ReDrug exports from India shot up 30.7% for the first 10 months of 2008-09 ended January 2009 compared with the previous year, backed by weak...
Load More
